Filter
413
Text search:
drug
stability
testing
Featured
39
106
Language
Document type
245
60
56
30
12
4
3
3
Countries / Regions
21
14
13
12
12
11
10
10
9
9
8
8
8
7
6
6
5
5
4
4
4
4
4
4
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
171
39
19
13
13
12
8
Toolboxes
35
34
30
27
23
15
15
14
10
8
6
5
4
4
4
4
3
3
2
2
1
1
1
Pharmaceutical News
Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis
Consultation Documents
Lamivudine and tenofovir disoproxil fumarate tablets (lami
...
The National Guidelines for HIV-1 Viral Load Laboratory Testing support plans to scale up viral load (VL) testing to reach the 90-90-90 targets in India. This phased scale-up includes the setup of 7
...
Toolkit
HIV Treatment and Care
These policy guidelines provide a strategic approach and new recommendations for integrated TB and HIV services for patients suffering from substance-abuse addiction. The key recommendations fall under three main categories: joint planning, key interventions, and overcoming barriers.
The Lancet Global Health 2016 Published Online August 30, 2016
http://dx.doi.org/10.1016/S2214-109X(16)30175-9
J Pharm Pharm Sci (www.cspsCanada.org) 16(3) 441 - 455, 2013
This document provides a systematic approach in developing a coordinated, standardized, reliable, efficient, cost-effective, and sustainable specimen transport and referral system to support IVHD and VL testing networks. This document provides techn
...
Accessed: 28.03.2019
Doc. No.: INS/GDL/001-(Annexes)
Emergence of antimicrobial resistance is a result of the use, overuse and misuse of antibiotics both in humans and animals. In Ethiopia, there are indications on the misuse of antibiotics by health care providers’, unskilled practitioners, and drug
...
Opiates, cocaine, cannabis
World Drug Report 2017
-3-
Accessed: 14.03.2019
Drug Advisory Board
World Drug Report 2018
-4-
International Journal of Drug Policy 24 (2013) e91-98
28 January 2021. The purpose of this document is to provide interim guidance on laboratory biosafety related to the testing of clinical specimens of patients.
